Centre de Recherche en Rhumatologie et Immunologie, Centre de recherche du CHUQ-CHUL et Faculté de Médecine de l'Université Laval, 2705 Boulevard Laurier, local T1-49, Québec, QC, G1V 4G2, Canada.
Biochem Pharmacol. 2011 Jan 1;81(1):144-56. doi: 10.1016/j.bcp.2010.09.014. Epub 2010 Sep 19.
Although phosphatidic acid (PA) regulates a wide variety of physiological processes, its targets remain poorly characterized in human neutrophils. By co-sedimentation with PA-containing vesicles we identified several PA-binding proteins including vesicle amine transport protein-1 (VAT-1), Annexin A3 (ANXA3), Rac2, Cdc42 and RhoG in neutrophil cytosol. Except for ANXA3, protein binding to PA-containing liposomes was calcium-independent. Cdc42 and RhoG preferentially interacted with PA whereas VAT-1 bound to PA or phosphatidylserine with the same affinity. VAT-1 translocated to neutrophil membranes upon N-formyl-methionyl-leucyl-phenylalanine (fMLF) stimulation. Inhibition of fMLF-induced PLD activity with the Src kinase inhibitor PP2, the selective inhibitor of PLD FIPI, or of PA formation with primary alcohols reduced VAT-1 translocation. In contrast, inhibition of PA hydrolysis with propranolol enhanced fMLF-mediated VAT-1 recruitment to membranes. PMA also redistributed VAT-1 to membranes in a PKC- and PLD-dependent manner. Though fMLF and PMA increased VAT-1 phosphorylation, different kinases appear to be involved. Cell fractionation revealed that a pool of VAT-1 was co-localized with primary, secondary and tertiary granules and plasma membrane markers in resting neutrophils. Stimulation with fMLF enhanced VAT-1 co-localization with CD32a, a plasma membrane marker. Confocal microscopy revealed that VAT-1 decorates granular structures at the cell periphery and double labeling with VAT-1/lactoferrin antibodies showed a partial co-localization with secondary granules in control and fMLF-stimulated cells. Characterization of these putative PA-binding proteins constitutes another step forward for a better understanding of the role of PLD-derived PA in neutrophil physiology.
虽然磷脂酸 (PA) 调节着广泛的生理过程,但在人类中性粒细胞中,其靶标仍未得到很好的描述。通过与含有 PA 的囊泡共沉淀,我们鉴定出几种与 PA 结合的蛋白质,包括囊泡胺转运蛋白-1(VAT-1)、膜联蛋白 A3(ANXA3)、Rac2、Cdc42 和 RhoG,这些蛋白质存在于中性粒细胞胞质中。除了 ANXA3,与含有 PA 的脂质体结合的蛋白质是不依赖于钙的。Cdc42 和 RhoG 优先与 PA 相互作用,而 VAT-1 与 PA 或磷脂酰丝氨酸具有相同的亲和力。VAT-1 在 N-甲酰基-甲硫氨酸-亮氨酸-苯丙氨酸(fMLF)刺激下向中性粒细胞膜转位。用Src 激酶抑制剂 PP2、PLD 的选择性抑制剂 FIPI 或伯醇抑制 fMLF 诱导的 PLD 活性,减少 VAT-1 转位。相反,用普萘洛尔抑制 PA 水解增强了 fMLF 介导的 VAT-1 向膜的募集。PMA 也以 PKC 和 PLD 依赖的方式重新分配 VAT-1 到膜上。虽然 fMLF 和 PMA 增加了 VAT-1 的磷酸化,但似乎涉及不同的激酶。细胞分级分离显示,在静止的中性粒细胞中,VAT-1 与初级、次级和三级颗粒以及质膜标志物的一个池共定位。用 fMLF 刺激增强了 VAT-1 与质膜标志物 CD32a 的共定位。共聚焦显微镜显示,VAT-1 装饰着细胞边缘的颗粒结构,VAT-1/乳铁蛋白抗体的双标记显示,在对照和 fMLF 刺激的细胞中,与次级颗粒有部分共定位。对这些假定的 PA 结合蛋白的表征是更好地理解 PLD 衍生的 PA 在中性粒细胞生理学中的作用的又一步。